Molecular Targets and Potential Mechanisms of Luteolin Against Cervical Carcinoma: Integrative Approach Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulations, and In Vitro Validation.

Authors

Xinyu Pan, Dan Liu, Junliang Chen, Hanlu Deng, Xiangyu Cao

Published in

Chemistry & biodiversity. Volume 23. Issue 10. Pages e71860.

Abstract

Cervical carcinoma ranks among the most prevalent malignant neoplasms in gynecology, distinguished by elevated incidence and fatality rates. Therefore, novel treatment strategies are urgently needed. An effective approach for the revelation of natural active components and their molecular mechanisms was provided by network pharmacology, molecular dynamics simulation, and cell biology methods. Olives contain various bioactive components with antioxidant and antitumor activities. Among these, luteolin, as one of the main natural flavonoids, was proven to possess significant antitumor activity. This research identified C-X-C chemokine Ligand 8 (CXCL8) as a significant target linked to the progression of cervical carcinoma, and luteolin was found to have a strong and stable interaction with CXCL8 that significantly downregulated its expression in HeLa cells. Meanwhile, luteolin could significantly suppressed the proliferation, migration, and lipid droplet formation capacity of HeLa cells. These results suggested that luteolin derived from olives could potentially inhibit HeLa cells through the regulation of CXCL8 and offered a theoretical foundation for the utilization of olive-derived bioactive components in the antitumor treatment of cervical carcinoma.

PMID:
42904790
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.